Glympse Bio

Glympse Bio, Inc. is the developer of a diagnostic platform that facilitates non-invasive disease monitoring through biomarker technology. The company's platform uses precisely designed diagnostic agents to probe specific disease states in the body and then relay the information to urine for analysis, enabling physicians to monitor various human diseases non-invasively and predictively, such as certain cancers, blood clotting disorders, and liver fibrosis, faster and more accurately than currently available biomarker technologies.